1. Home
  2. SRRK vs CHRD Comparison

SRRK vs CHRD Comparison

Compare SRRK & CHRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$41.57

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Logo Chord Energy Corporation

CHRD

Chord Energy Corporation

HOLD

Current Price

$151.60

Market Cap

8.0B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
CHRD
Founded
2012
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
8.0B
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
SRRK
CHRD
Price
$41.57
$151.60
Analyst Decision
Strong Buy
Buy
Analyst Count
18
18
Target Price
$70.44
★ $176.88
AVG Volume (30 Days)
★ 1.8M
584.2K
Earning Date
11-13-2026
11-04-2026
Dividend Yield
N/A
★ 3.37%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 11.14
Revenue
N/A
N/A
Revenue This Year
N/A
$49.78
Revenue Next Year
$2,404.46
N/A
P/E Ratio
★ N/A
$13.89
Revenue Growth
N/A
N/A
52 Week Low
$27.07
$84.25
52 Week High
$61.76
$157.06

Technical Indicators

Market Signals
Indicator
SRRK
CHRD
Relative Strength Index (RSI) 30.05 68.26
Support Level $39.69 $130.44
Resistance Level $48.59 $157.06
Average True Range (ATR) 1.89 3.60
MACD -0.23 1.92
Stochastic Oscillator 14.72 98.49

Price Performance

Historical Comparison
SRRK
CHRD

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About CHRD Chord Energy Corporation

Chord Energy Corp is an independent exploration and production (E&P) company engaged in the acquisition, exploration, development and production of crude oil, NGL and natural gas prominently in the Williston Basin, with limited non-operated interests in the Marcellus Shale. It operates in one reportable business segment, which is the E&P of crude oil, NGL and natural gas. The company derives revenue from the sale of crude oil, NGL and natural gas production.

Share on Social Networks: